COCO SILVIA

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186 [10.1016/j.biopha.2025.118044]. Detail

Meanti, R., Bresciani, E., Rizzi, L., Coco, S., Zambelli, V., Dimitroulas, A., et al. (2023). Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis. CURRENT NEUROPHARMACOLOGY, 21(12), 2376-2394 [10.2174/1570159X20666220915103613]. Detail

Meanti, R., Licata, M., Rizzi, L., Bresciani, E., Molteni, L., Coco, S., et al. (2023). Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24020993]. Detail

Rizzi, L., Turati, M., Bresciani, E., Anghilieri, F., Meanti, R., Molteni, L., et al. (2022). Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears. BIOMEDICINES, 10(11) [10.3390/biomedicines10112909]. Detail

D'Aloia, A., Molteni, L., Gullo, F., Bresciani, E., Artusa, V., Rizzi, L., et al. (2021). Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(6), 1-24 [10.3390/ijms22063054]. Detail